Does TELOTRISTAT ETHYL Cause Neoplasm progression? 73 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 73 reports of Neoplasm progression have been filed in association with TELOTRISTAT ETHYL (Xermelo). This represents 1.3% of all adverse event reports for TELOTRISTAT ETHYL.
73
Reports of Neoplasm progression with TELOTRISTAT ETHYL
1.3%
of all TELOTRISTAT ETHYL reports
7
Deaths
9
Hospitalizations
How Dangerous Is Neoplasm progression From TELOTRISTAT ETHYL?
Of the 73 reports, 7 (9.6%) resulted in death, 9 (12.3%) required hospitalization.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TELOTRISTAT ETHYL. However, 73 reports have been filed with the FAERS database.
What Other Side Effects Does TELOTRISTAT ETHYL Cause?
Diarrhoea (798)
Nausea (610)
Constipation (592)
Abdominal pain (514)
Off label use (495)
Fatigue (395)
Flatulence (390)
Flushing (344)
Headache (320)
Drug ineffective (317)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which TELOTRISTAT ETHYL Alternatives Have Lower Neoplasm progression Risk?
TELOTRISTAT ETHYL vs TEMAZEPAM
TELOTRISTAT ETHYL vs TEMODAR
TELOTRISTAT ETHYL vs TEMOZOLOMIDE
TELOTRISTAT ETHYL vs TEMSIROLIMUS
TELOTRISTAT ETHYL vs TENAMFETAMINE